Abstract Details

Title A Comparison of the Efficacy and Tolerability of Interferon Beta (IFN[beta]) Products Used as Initial or Follow-Up Therapy for the Treatment of Relapsing Multiple Sclerosis: Results from the QUASIMS Study

Topic

Presentation(s)

Poster/Presentation
Number 122

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Duarte G. Machado, MD, FAAN (Hartford Healthcare Neurology)	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal.
Michael A. De Georgia, MD (University Hospitals Cleveland Medical Center)	Dr. De Georgia has nothing to disclose.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��